Skip to main content
. 2016 Sep 17;7(50):82609–82619. doi: 10.18632/oncotarget.12089

Table 2. Stage Tis, Ta Risk-Matched Tumor Bank Cohort – 80 Patients.

Characteristic Progression (n = 16) N (%) No Progression (n = 64) N (%) P-Value
Median Age (IQR) 74 (60-78) 69 (62-78) 0.66
Male 16 (100) 63 (98) 1.00
High Grade* 9 (56) 37 (58) 0.91
CIS+ 9 (56) 27 (42) 0.31
Multifocal 10 (63) 19 (30) 0.01
> 3 cm 3 (19) 10 (16) 0.76
EORTC High-Risk Group** 9 (56) 37 (58) 0.91
Prior Local Treatment 1 (6) 5 (8) 1.00
Median Follow-up in Years (IQR) 6.6 (4.6-10.7) 5.5 (3.5-8.4) 0.32
*

2004 World Health Organization grade definitions

**

European Organisation for Research and Treatment of Cancer